Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes
Author(s) -
Alfonso Galderisi,
Jennifer L. Sherr,
Michelle VanName,
Lori Carria,
Melinda Zgorski,
Eileen Tichy,
Kate Weyman,
Eda Cengiz,
Stuart A. Weinzimer,
William V. Tamborlane
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-02265
Subject(s) - postprandial , medicine , glucagon , liraglutide , endocrinology , type 1 diabetes , hyperglucagonemia , diabetes mellitus , meal , type 2 diabetes , insulin , glucagon like peptide 1
Postprandial hyperglycemia remains a challenge in type 1 diabetes (T1D) due, in part, to dysregulated increases in plasma glucagon levels after meals.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom